Sign in
Not yet recruitingPhase 1

Artemisia Annua Infusion for the Treatment of Asymptomatic Plasmodium Falciparum Infection

Key facts

Who runs it
Centre de Recherche Médicale de Lambaréné
Where
Gabon1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
Phase
Phase 1
People taking part
20 people, planned
Started
1 Sept 2026
Expected to end
Jun 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Artemisia Annua Leaf
  • Centaurii herba
Record updated
15 September 2026

Who can take part

Age
18 years to 45 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Age: 18 to 45 years
  • Absence of fever (body temperature <37.5ºC axillary or <38.0°C oral, rectal or tympanic temperature)
  • Asymptomatic P. falciparum infection with parasitemia between 500 and 2,000 asexual P. falciparum parasites per μl of blood
  • Have been living in an endemic area for at least 5 years
  • Written informed consent from the participant
  • Residence in the vicinity of the study centre
  • Willingness to comply with the follow-up schedule

Who cannot take part

  • Intake of any antimalarial drug or antibiotic with antimalarial activity within the previous 28 days and/or after half-life time
  • History of fever over the last 72 hours
  • Non-Plasmodium falciparum infection
  • Known history or evidence of clinically significant medical disorders
  • Known hypersensitivity and contraindications to any study medication
  • Haemoglobin concentration <7 g/dL
  • Presence of signs and symptoms related by the medical doctor to malaria
  • Severe malnutrition
  • Pregnancy or lactation
  • Participation in other interventional studies

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to determine whether Artemisia annua dried leaves, used as an infusion, can treat individuals with malaria parasites but no symptoms. The main question it aims to answer is:

Read full original descriptionShow less

Can Artemisia annua infusion be used to treat malaria?

Researchers will compare those receiving Artemisia annua infusion with those receiving an infusion of Centaurii herba (which has no effect on malaria parasites) to see whether all individuals treated with Artemisia annua infusion are cured, which should not be the case for those receiving Centaurii herba infusion.

Participants will

* drink Artemisia annua infusion over seven days (three days at our research centre and four days at their home * visit the research centre once a week for three weeks after treatment for one month for safety reasons

The 2 groups in the trial

  • Artemisia armTreatment being tested

    Treatment: Artemisia Annua Leaf

  • Control armPlacebo, for comparison

    Treatment: Centaurii herba

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Assessment of the Safety and Efficacy of Artemisia Annua Infusion Preparation for the Treatment of Asymptomatic Plasmodium Falciparum Infection in Semi-immune Adults in Gabon
Criteria questions
Built from NCT07819825, who can take part
Record updated
15 September 2026